Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma

Diffuse malignant pleural mesothelioma (MPM) is the third most common lung malignancy showing rising incidence with 250,000 deaths expected from it in Western Europe over the next 35 year. The tumour is generally resistant to conventional treatment and there is urgent need for novel preventative and...

Ausführliche Beschreibung